J&J Shares Climb 2% After Key Announcement
J&J's shares increased by 2% post-announcement, while AstraZeneca's remained stable. Discover what fueled this stock movement and market reaction.
J&J's shares rose 2% following the announcement, while AstraZeneca's shares showed little change.